Korean Pharmacopuncture Institute

The Korean Pharmacopuncture Institute (KPI) is a specialized research and development organization and manufacturer based in South Korea, focused on the integration of traditional Korean medicine with modern pharmacology. The institute is the primary developer of pharmacopuncture, a therapeutic modality where standardized herbal extracts are injected into specific acupoints to provide combined chemical and mechanical stimulation. KPI operates a large-scale, GMP-compliant herbal medicine dispensary that produces a variety of injectable extracts, including Sweet Bee Venom and Mountain Ginseng Pharmacopuncture. Their work encompasses basic research, clinical trials, and the standardization of traditional medicine for treating chronic pain, musculoskeletal disorders, and cancer-related symptoms. KPI serves as a central hub for the scientific advancement and clinical application of pharmacopuncture both in Korea and internationally.